Tariff Relief: US Postpones Duties on Singaporean Pharma Amidst Supply Chain Concerns

Trump's Bold New Blueprint: Unveiling Ambitious Plans to Slash Prescription Drug Costs

Rethinking Drug Costs: Trump's Bold Bid to Reshape Pharmaceutical Pricing

Indian Pharma Soars: US BIOSECURE Act Triggers Major Opportunity Shift

White House Shelves Generic Drug Tariffs, Paving the Way for Indian Pharma's Continued Success

NHRC Demands Answers Amidst Tragic Cough Syrup Deaths: A Call for Accountability

Europe's Bold New Pharma Gambit: A High-Stakes Bet on Access Over Profit?

A Bitter Truth: India's Pharmaceutical Industry Under Scrutiny Amidst Global Cough Syrup Tragedies

The Enduring Battle: Trump, Pfizer, and the Shifting Tides of Prescription Drug Pricing

The Pharmaceutical Tsunami: How a Second Trump Term Could Reshape Drug Pricing, Medicare, and Vaccines

Transatlantic Tremors: How US Drug Pricing Reforms Are Reshaping the Global Pharmaceutical Landscape

TrumpRx Unveils Groundbreaking Platform to Dramatically Cut Prescription Drug Costs

Pfizer's Bold New Chapter: Shares Soar as Pharma Giant Commits to Sweeping US Drug Price Cuts

Trump's Trade Winds: Navigating the Storm for India's Pharma Giants

Unveiling the Conflict: Trump's Anti-Tylenol Advisor and Hidden Payments from Competitors

Trump's Tariff Gamble: Experts Unpack the Real Cost of Pharma Duties

US Tariffs Threaten India's Generic Pharma Powerhouse: Himachal Manufacturers Sound Alarm

Trump's Tariff Threat: A Double-Edged Sword for India's Pharma Manufacturing Ambitions

Trump's Tariff Tempest: Why a 100% Drug Tax Could Sink India's Pharma Giants and Ignite a US Healthcare Crisis

India's Pharmaceutical Powerhouse Under Siege: Navigating Trump's Tariff Tempest

Trump's Bold Tariff Escalation: 100% on Pharma Imports, Expanded Duties on Furniture & Heavy Trucks

A New Frontier in Health: RFK Jr. Challenges Conventional Wisdom at the UN on Chronic Disease

The Enduring Saga of Drug Prices: Trump's Lingering Shadow on Healthcare Affordability

Dr. Evelyn Jarvis Unmasks 'Tylenol Briefing' as a Trove of Pseudoscience, Sparking Public Outcry

Kenvue Stock Under Siege: Trump's Tylenol Warning Rekindles Autism Lawsuits, But Retail Bulls Hold Firm

Indian Healthcare Boom: Rs 13,000 Cr IPO Wave on the Horizon

Indian Pharma Sector Poised for Massive Rs 45,000 Crore Investment Boom by FY26, ICRA Reports

Novo Nordisk's Strategic Overhaul: 9,000 Job Cuts to Propel Future Dominance

Trump's Bold Play: Mandating Sweeping Side Effect Disclosures in Drug Ads

Unveiling RFK Jr.'s Audacious Vision: The 'Make America Healthy Again' Blueprint

RFK Jr.'s 'Make America Healthy Again': Unpacking the Vision for Public Health

Unlocking Breakthroughs: Cell Lysis and Disruption Market Set to Explode Past $10.9 Billion by 2032

The WHO's Bold Stance: Backing Weight-Loss Wonders While Championing Affordable Access

Fiery Senate Showdown: RFK Jr. Ignites Heated Debate on Vaccine Access with Bipartisan Senators

Gilead's Visionary Expansion: Foster City Emerges as a Global Biotech Epicenter

India's Pharma Marketing Rules Get a Mandatory Makeover: Simplified Compliance, But What About the Finer Print?

Trump Ignites Debate: Demands Drugmakers Justify COVID-19 Vaccine Claims

Trump's Bold Drug Tariff: A Double-Edged Sword for American Healthcare?

India's 'Pharmacy of the World' Title at Risk: Urgent GST Reforms Needed for Pharma Exports